Globally, about 18 million people will be diagnosed with cancer and approximately 10 million people will die from cancer this year. Between 30–50% of these cancer cases are potentially preventable today, a fact that highlights that prevention remains one of the most effective and cost-effective long-term strategies to reduce the global cancer burden.
The Zaporizhzhia nuclear power facility, the largest in Europe, with six reactors, has been under Russian control since March, 4, 2022.
Progress against cancer, as brought about by high quality academic cancer centers, requires individual excellence from experts who apply distinct, highly specific skill sets to a common goal within the cancer center. The cancer center coordinates and supports these efforts.
The U.S. Preventive Services Task Force’s new guidelines to offer mammography from age 40 will save many lives.
Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG).
I have no doubt that our professional associations in cancer research and oncology and our NCI in the U.S. care about the plight of cancer scientists and oncologists who have been displaced due to war or violence in their home countries.
In September of 2021, an unprecedented event occurred that may have escaped your notice. The New England Journal of Medicine and over 200 other health care publications simultaneously published joint editorials alerting the greater medical community to the “catastrophic” public health and environmental impacts of climate change.1
Over the years, I have gained extensive experience with academic cancer center External Advisory Boards, including hosting multiple EAB meetings at my own cancer center, chairing the EABs of nine other NCI designated cancer centers, and serving on many others.
The shortage of certain cancer drugs is a serious and life-threatening issue for cancer patients across the United States. This, however, is not a new issue. Drug shortages are a cyclical event, and we need a durable solution to ensure that cancer patients have access to the drugs and the treatment they need to survive.
Last year, the NIH announced that at the direction of Congress, the organization would tighten rules for reporting sexual and workplace harassment by investigators funded by the NIH.
